Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Analytical HPLC method validation for C-11 palmitic acid

Ping Fang and Mark Jacobson
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1146;
Ping Fang
1Department of Radiology, Mayo Clinic, Rochester, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Jacobson
1Department of Radiology, Mayo Clinic, Rochester, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1146

Objectives C-11 Palmitic acid (PA) is a fatty acid metabolism imaging agent. We describe herein a method for validation of an analytical HPLC procedure following FDA guidance. Both UV and radio-detectors were validated for linearity, accuracy, precision, range, quantitation limit (QL) and detection limit(DL).

Methods : 1) UV detector: HPLC, Phenomenex Luna 3µ C-8(2) 100A column 4.6mm X 150mm, MeCN/0.1%TFA water (90/10), 1.0 mL/min, 10µL loop, UV 215nm. A series of reference standards in methanol (1.0 µg/mL-1000.0 µg/mL) were prepared for testing. 2) Radio-detector: Flow Count, Range 200K cps. A series of radioactive concentrations of F18 fluoride in water (76 µCi/mL-66.7 mCi/mL@injection) were prepared for testing.

Results 1) UV detector: R2 = 0.9999. Recovery for 25.0, 250.0 and 1000.0 µg/mL standard concentration are 102.12%, 98.30% and 100.31% respectively. Precision is shown as coefficient of variation (COV), and is < 3.85%. Accuracy, precision and linearity data for PA are acceptable in the range of 25.0 and 1000.0 µg/mL. The QL is 25.0 µg/mL and DL is 5.0 µg/mL. 2) Radio-detector: R2 = 0.9992 for 1.92 to 53.4 mCi/mL @injection. The recovery for 1.92, 24.73 and 53.4 mCi/mL standards were 97.7%, 100.48% and 100.40% respectively. The COV is 1.38% from different time injections of 9.57 mCi/mL standard; The radioactive concentration range between 1.92-53.4 mCi/mL is acceptable. QL and DL are 1.107 and 0.332 mCi/mL respectively.

Conclusions We have validated the HPLC procedure for chemical and radiochemical purity for C-11 PA. PA is not water soluble and it has very low response to UV or refractive index detectors. The QL is too high to accurately determine the mass of PA and therefore specific activity, but it can be used for radiochemical identity confirmation.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Analytical HPLC method validation for C-11 palmitic acid
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Analytical HPLC method validation for C-11 palmitic acid
Ping Fang, Mark Jacobson
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1146;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Analytical HPLC method validation for C-11 palmitic acid
Ping Fang, Mark Jacobson
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1146;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • A general 11C-carboxylation approach mediated by fluoride-desilylation of organosilanes
  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Radiopharmacy Posters

  • Improved synthesis and purification of C-11 PBR-28
  • Preclinical and a first-in man studies on [11C]CB184 for imaging 18 kDa translocator protein by positron emission tomography
  • Synthesis of [18F]Tetrafluoroborate ([18F]TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model
Show more Special MTA: Radiopharmacy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire